Webinars

FEB 14, 2019 10:30 AM PST

Integrating In Vitro Microtissues and In Vivo endpoints in Drug Discovery & Development

Presented at: Laboratory Animal Sciences 2019

C.E. Credits: RACE

Speaker

Matthew Wagoner, PhD
Associate Director of Mechanistic and Investigative Toxicology, Takeda Pharmaceuticals
Biography
Matt Wagoner leads the Global Investigatory Toxicology network for Takeda Pharmaceuticals, where their team applys microphysiological systems (MPS) as predictive and mechanistic toxicology tools in support of discovery-phase projects. Before Takeda, Matt led the mRNA safety strategy for AstraZeneca Pharmaceuticals, and worked to develop and deploy MPS tools in support of projects. Matt has his PhD in Molecular and Cellular Pharmacology from the University of Wisconsin-Madison and bachelors in biochemistry from the University of Illinois Urbana Champaign.

Abstract

This presentation will discuss and review the promise and potential of 3D Microtissues, and the challenges of using these Microtissues as Hazard ID tools. Lastly, we will discuss the potential application of Neural Microtissues in drug discovery screening.

Learning Objectives:

1. Understanding the strengths and limitations of in vitro and in vivo assays for hazard identification and risk assessment.
2. Examining how 3D Microtissues can improve hazard identification in drug discovery, and de-risking during drug development.

Show Resources

You May Also Like

NOV 16, 2020 8:00 AM PST

C.E. CREDITS

NOV 16, 2020 8:00 AM PST

Targeted single-cell RNA sequencing enables genome-scale CRISPR...

Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...

Speaker: Wieland Keilholz, Ph.D. , Pawel Zajac, Ph.D. , Dr. Tilmann Buerckstuemmer

Sponsored By: Illumina

OCT 08, 2020 7:00 AM PDT

C.E. CREDITS

OCT 08, 2020 7:00 AM PDT

Protect your cells with proper pipetting - How liquid handling...

DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...

NOV 18, 2020 8:00 AM PST

C.E. CREDITS

NOV 18, 2020 8:00 AM PST

Whole-organ mapping using AI and light sheet microscopy

DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...

DEC 02, 2020 8:00 AM PST

C.E. CREDITS

DEC 02, 2020 8:00 AM PST

Optimize your bioprocess - From shaker to bioreactor

DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...

NOV 10, 2020 7:00 AM PST

C.E. CREDITS

NOV 10, 2020 7:00 AM PST

Move Forward with Automation

DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...

OCT 22, 2020 8:00 AM PDT

C.E. CREDITS

OCT 22, 2020 8:00 AM PDT

Driving lab efficiency with PCR power

Abstract: Detection and/or amplification of target DNA sequences by polymerase chain reaction (PCR) is a prevalent method in molecular biology. PCR has a broad range of applications, includi...